ViroPharma (VPHM) Could Draw 50% Premium in Takeover
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Deutsche Bank Cuts ViroPharma (VPHM) to Hold; Takeout Premium Reflected in Price
September 19, 2013 7:28 AM EDTDeutsche Bank downgraded ViroPharma (NASDAQ: VPHM) from Buy to Hold with a price target of $43.00 (from $38.00). Analyst Robyn Karnauskas thinks the stock's current price reflects most of the M&A takeout premium.
"Press sources on 9/13 (Bloomberg) stated that Viropharma has hired... More
UPDATE: ViroPharma Inc. (VPHM) Hires Goldman to Explore Sale - Bloomberg
September 13, 2013 1:00 PM EDT(Updated - September 13, 2013 1:08 PM EDT)
ViroPharma Inc. (Nasdaq: VPHM) has attracted takeover interest from Sanofi (NYSE: SNY) and Shire (NYSE: SHPG), according to Bloomberg sources. The company has hired Goldman Sachs to manage a potential auction, and the Bank has is seeking other bidders.... More
